
Pulmonologist

No OPD information available
Chronic Obstructive Pulmonary Disease (COPD)
Bronchiectasis
Obesity Hypoventilation Syndrome (OHS)
Acute Interstitial Pneumonia
Asbestosis
Asthma
Cystic Fibrosis
Interstitial Lung Disease
Obesity
Obstructive Sleep Apnea
Sarcoidosis
Urinary Incontinence
Angela T. Burge is a female healthcare provider who helps people with different lung and breathing problems like COPD, asthma, and sleep apnea. She also treats conditions like obesity and urinary incontinence.
Angela T. Burge uses special skills and treatments to help her patients breathe better and improve their overall health. She is good at understanding and treating lung diseases and other related health issues.
Angela T. Burge talks to her patients in a way that makes them feel comfortable and cared for. Patients trust her because she listens to their concerns and explains things in a simple and clear manner.
To stay updated with the latest medical knowledge, Angela T. Burge reads new research studies and attends conferences and training sessions. This helps her provide the best care for her patients based on the most recent information.
Angela T. Burge works well with other medical professionals, like doctors and nurses, to make sure her patients get the best care possible. She shares information and collaborates with colleagues to improve patient outcomes.
Angela T. Burge's work has positively impacted many patients' lives by helping them breathe easier, manage their conditions better, and improve their overall quality of life. Her dedication to providing high-quality care has made a difference in the lives of those she treats.
In one of her notable publications, Angela T. Burge discussed how to assess exercise capacity in adults with chronic respiratory disease safely and effectively. She also conducted a clinical trial on the benefits and costs of home-based pulmonary rehabilitation for COPD patients, which has helped improve treatment options for these individuals.
Enrollment Status: Completed
Published: August 14, 2019
Intervention Type: Behavioral
Study Drug:
Study Phase: Phase 3
